The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 10, 2020
Filed:
Apr. 02, 2019
Applicants:
Hubit Genomix, Inc., Tokyo, JP;
Fuso Pharmaceutical Industries, Ltd., Osaka, JP;
Inventors:
Assignees:
HUBIT GENOMIX, INC., Tokyo, JP;
FUSO PHARMACEUTICAL INDUSTRIES, LTD., Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/415 (2006.01); A61P 13/12 (2006.01); A61K 31/192 (2006.01); A61K 31/167 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/415 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 31/167 (2013.01); A61K 31/192 (2013.01); A61P 13/12 (2018.01);
Abstract
The present invention provides a drug capable of preventing or treating diabetic nephropathy. The present invention relates to a prophylactic and/or therapeutic drug for diabetic nephropathy, comprising a RARγ agonist as an active ingredient. The present invention also provides a prophylactic and/or therapeutic drug for renal anemia; a drug inhibiting the expression of type IV collagen in mesangial cells; a drug inhibiting the expression of BMP4 in mesangial cells; and a drug inhibiting fibrosis in the renal tubulointerstitium.